Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Finance Receivables10.74M93.03%
Pharmaceutical Development and Other804K6.97%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States37.76M100.00%